Weekly 5-fluorouracil and leucovorin: Achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resection

被引：0
|
作者：
Waterhouse, C
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2005年 / 181卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：58 / 60
页数：3
相关论文
共 50 条
  • [41] SURGICAL RESECTION OF METASTASES (MTS) AFTER BIWEEKLY CHEMOTHERAPY WITH IRINOTECAN, OXALIPLATIN AND 5-FLUOROURACIL/LEUCOVORIN (FOLFOXIRI) IN INITIALLY UNRESECTABLE METASTATIC COLORECTAL CANCER (MCRC)
    Masi, G.
    Cupini, S.
    Marcucci, L.
    Cerri, E.
    Loupakis, F.
    Allegrini, G.
    Ricci, S.
    Brunetti, I.
    Andreuccetti, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2004, 15 : 66 - 67
  • [42] Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
    André, T
    Louvet, C
    Raymond, E
    Tournigand, C
    de Gramont, A
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1251 - 1253
  • [43] Surgical resection of metastases (mts) after biweekly chemotherapy with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI) in initially unresectable metastatic colorectal cancer (MCRC).
    Falcone, A
    Masi, G
    Cupini, S
    Marcucci, L
    Ricci, S
    Brunetti, I
    Cerri, E
    Fontana, E
    Andreuccetti, M
    Allegrini, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 258S - 258S
  • [44] EARLY ADJUVANT INTRAPORTAL CHEMOTHERAPY WITH 5-FLUOROURACIL AFTER HEPATIC RESECTION FOR COLORECTAL METASTASES - A PRELIMINARY CLINICAL AND PHARMACOKINETIC STUDY
    SEITZ, JF
    AUBERT, C
    GIOVANNINI, M
    DELPERO, JR
    HOUVENAEGHEL, G
    GUERINEL, G
    CARCASSONNE, Y
    BULLETIN DU CANCER, 1989, 76 (10) : 1127 - 1132
  • [45] A pilot study of adjuvant chemotherapy with double modulation of 5-Fluorouracil by Methotrexate and Leucovorin in gastric cancer patients
    De Vita, F
    Orditura, M
    Auriemma, A
    Infusino, S
    Catalano, G
    PANMINERVA MEDICA, 1999, 41 (01) : 35 - 38
  • [46] Pulmonary fibrosis after chemotherapy with oxaliplatin and 5-fluorouracil for colorectal cancer
    Mundt, Pamela
    Mochmann, Hans-Christian
    Ebhardt, Harald
    Zeitz, Martin
    Duchmann, Rainer
    Pauschinger, Matthias
    ONCOLOGY, 2007, 73 (3-4) : 270 - 272
  • [47] Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: A GISCAD study
    Zaniboni, A
    Labianca, R
    Martignoni, G
    Barni, S
    Vinci, M
    Vaghi, M
    Pirovano, M
    Facendola, G
    Marini, G
    Luporini, G
    JOURNAL OF CHEMOTHERAPY, 1996, 8 (01) : 82 - 84
  • [48] Oxaliplatin with weekly bolus 5-fluorouracil and leucovorin in pretreated advanced colorectal cancer patients: A phase II study
    Yang, TS
    Chen, JS
    Tang, RP
    Chiang, JM
    Hsieh, PS
    Yeh, CY
    Changchien, CR
    CHEMOTHERAPY, 2003, 49 (04) : 194 - 199
  • [49] Survival outcomes after toxicity-related dose modification of 5-fluorouracil, leucovorin and oxalipatin (FOLFOX) in stage III, resected colorectal cancer patients
    Ha, F. J.
    Aksakal, G.
    Chong, G.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection
    Sugimachi, K
    Maehara, Y
    Ogawa, M
    Kakegawa, T
    Tomita, M
    Akiyoshi, T
    CANCER, 1996, 77 (01) : 36 - 43
12345